14th Oct 2019 12:21
Mereo BioPharma Group plc
("Mereo" or the "Company")
Notification of Director Dealing
London, October 14, 2019 - Mereo BioPharma Group plc (AIM: MPH, NASDAQ: MREO), a clinical stage UK based biopharmaceutical company focused on rare diseases, received notification that on October 11, 2019, Peter Fellner, Chairman of the Board of Directors of Mereo, purchased 23,800 Ordinary Shares at a price of GBP0.60 per share. On the same day, Peter Fellner also purchased 1,700 Ordinary Shares at a price of GBP0.61 per share.
The below announcement and notification is made in accordance with the EU Market Abuse Regulation. The form required under the EU Market Abuse Regulation follows.
1 | Details of the person discharging managerial responsibilities | |||||
a) | Name | Peter Fellner | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chairman of the Board of Directors | ||||
b) | Initial notification/ Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Mereo BioPharma Group plc | ||||
b) | LEI | 213800U8JQHIJOS5AS09 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument and identification code | MEREO BIOPHARMA GROUP PLC ORDINARY SHARES
| ||||
b) | Nature of the transaction | PURCHASE | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information: volume, Price | Aggregated volume: 23800 Aggregated price: GBP0.60 | ||||
e) | Date of the transaction | 2019-10-11 | ||||
f) | Place of the transaction | AIMX | ||||
1 | Details of the person discharging managerial responsibilities | |||||
a) | Name | Peter Fellner | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chairman of the Board of Directors | ||||
b) | Initial notification/ Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Mereo BioPharma Group plc | ||||
b) | LEI | 213800U8JQHIJOS5AS09 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument and identification code | MEREO BIOPHARMA GROUP PLC ORDINARY SHARES
| ||||
b) | Nature of the transaction | AIMX | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information: volume, Price | Aggregated volume: 1700 Aggregated price: GBP0.61 | ||||
e) | Date of the transaction | 2019-10-11 | ||||
f) | Place of the transaction | AIMX | ||||
Related Shares:
MPH.L